Study: New Test May Detect Two Cancers Earlier

by: cancercompass

Researchers at Somalogic Inc., a privately held company focused on biomarker technology, presented at an American Association for Cancer Research meeting in Denver this week.

The company stated that a new blood screening technology will allow doctors to diagnose pancreatic cancer and mesothelioma patients at earlier stages.

"Currently these cancers are detected at an advanced stage, where the possibility of cure is minimal," Rachel Ostroff, clinical research director of Somalogic Inc, told Reuters. "Detection of these aggressive cancers at an earlier stage would identify patients for early treatment, which may improve their survival and quality of life."

To learn more about the cancers featured in this post, please visit our pancreatic cancer information and lung cancer information pages.